Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosa Terracciano

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Frontiers in Pharmacology|October 13, 2023
Seminal plasma untargeted metabolomic and lipidomic profiling for the identification of a novel panel of biomarkers and therapeutic targets related to male infertilitySerena Correnti, Mariaimmacolata Preianò, Annalisa Fregola, et al.
Proteomics|December 30, 2015
Influence of storage conditions on MALDI-TOF MS profiling of gingival crevicular fluid: Implications on the role of S100A8 and S100A9 for clinical and proteomic based diagnostic investigationsMariaimmacolata Preianò, Giuseppina Maggisano, Nicola Lombardo, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 29, 2014
Assessment of pre-analytical and analytical variables affecting peptidome profiling of gingival crevicular fluid by MALDI-TOF mass spectrometryMariaimmacolata Preianò, Daniela Falcone, Giuseppina Maggisano, et al.
Pulmonary Pharmacology & Therapeutics|July 26, 2019
Real-life rapidity of benralizumab effects in patients with severe allergic eosinophilic asthma: Assessment of blood eosinophils, symptom control, lung function and oral corticosteroid intake after the first drug doseCorrado Pelaia, Maria Teresa Busceti, Alessandro Vatrella, et al.
Pulmonary Pharmacology & Therapeutics|July 7, 2016
Molecular and cellular mechanisms underlying the therapeutic effects of budesonide in asthmaGirolamo Pelaia, Alessandro Vatrella, Maria Teresa Busceti, et al.
Journal of Clinical Medicine|May 27, 2023
Pathobiology of Type 2 Inflammation in Asthma and Nasal PolyposisCorrado Pelaia, Giulia Pelaia, Angelantonio Maglio, et al.
Therapeutics and Clinical Risk Management|July 23, 2016
Role of biologics in severe eosinophilic asthma - focus on reslizumabGirolamo Pelaia, Alessandro Vatrella, Maria Teresa Busceti, et al.
Therapeutics and Clinical Risk Management|October 28, 2015
Pharmacologic rationale underlying the therapeutic effects of tiotropium/olodaterol in COPDGirolamo Pelaia, Alessandro Vatrella, Maria Teresa Busceti, et al.
Proteomics|December 25, 2016
A rapid differential display analysis of nasal swab fingerprints to distinguish allergic from non-allergic rhinitis subjects by mesoporous silica particles and MALDI-TOF mass spectrometryNicola Lombardo, Mariaimmacolata Preianò, Giuseppina Maggisano, et al.
Biomed Research International|June 5, 2018
Benralizumab: From the Basic Mechanism of Action to the Potential Use in the Biological Therapy of Severe Eosinophilic AsthmaCorrado Pelaia, Cecilia Calabrese, Alessandro Vatrella, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Frontiers in Pharmacology|October 13, 2023
Seminal plasma untargeted metabolomic and lipidomic profiling for the identification of a novel panel of biomarkers and therapeutic targets related to male infertilitySerena Correnti, Mariaimmacolata Preianò, Annalisa Fregola, et al.
Proteomics|December 30, 2015
Influence of storage conditions on MALDI-TOF MS profiling of gingival crevicular fluid: Implications on the role of S100A8 and S100A9 for clinical and proteomic based diagnostic investigationsMariaimmacolata Preianò, Giuseppina Maggisano, Nicola Lombardo, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 29, 2014
Assessment of pre-analytical and analytical variables affecting peptidome profiling of gingival crevicular fluid by MALDI-TOF mass spectrometryMariaimmacolata Preianò, Daniela Falcone, Giuseppina Maggisano, et al.
Pulmonary Pharmacology & Therapeutics|July 26, 2019
Real-life rapidity of benralizumab effects in patients with severe allergic eosinophilic asthma: Assessment of blood eosinophils, symptom control, lung function and oral corticosteroid intake after the first drug doseCorrado Pelaia, Maria Teresa Busceti, Alessandro Vatrella, et al.
Pulmonary Pharmacology & Therapeutics|July 7, 2016
Molecular and cellular mechanisms underlying the therapeutic effects of budesonide in asthmaGirolamo Pelaia, Alessandro Vatrella, Maria Teresa Busceti, et al.
Journal of Clinical Medicine|May 27, 2023
Pathobiology of Type 2 Inflammation in Asthma and Nasal PolyposisCorrado Pelaia, Giulia Pelaia, Angelantonio Maglio, et al.
Therapeutics and Clinical Risk Management|July 23, 2016
Role of biologics in severe eosinophilic asthma - focus on reslizumabGirolamo Pelaia, Alessandro Vatrella, Maria Teresa Busceti, et al.
Therapeutics and Clinical Risk Management|October 28, 2015
Pharmacologic rationale underlying the therapeutic effects of tiotropium/olodaterol in COPDGirolamo Pelaia, Alessandro Vatrella, Maria Teresa Busceti, et al.
Proteomics|December 25, 2016
A rapid differential display analysis of nasal swab fingerprints to distinguish allergic from non-allergic rhinitis subjects by mesoporous silica particles and MALDI-TOF mass spectrometryNicola Lombardo, Mariaimmacolata Preianò, Giuseppina Maggisano, et al.
Biomed Research International|June 5, 2018
Benralizumab: From the Basic Mechanism of Action to the Potential Use in the Biological Therapy of Severe Eosinophilic AsthmaCorrado Pelaia, Cecilia Calabrese, Alessandro Vatrella, et al.
Pageof 7